Penrose Inquiry

Last updated

The Penrose Inquiry was the public inquiry into hepatitis C and HIV infections from NHS Scotland treatment with blood and blood products such as factor VIII, often used by people with haemophilia. The event is often called the Tainted Blood Scandal or Contaminated Blood Scandal. [1]

Contents

It was not in the terms of reference of the inquiry to examine events in England, [2] a statutory public inquiry has never been held in England. [3] The Penrose Inquiry was set up by Scottish Government under the Inquiries Act 2005 and cost £12,123,754. [4] It was announced by Nicola Sturgeon on 23 April 2008. The Rt Hon Lord Penrose was the chairman of the inquiry. [5] Andrea Summers was the Solicitor for the Inquiry and following this Inquiry was appointed to the Scottish Child Abuse Inquiry. [6]

The Inquiry took six years and the victims branded it a "total whitewash". [7]

Publication

Lord Penrose did not attend the launch of the final report which was held on 25 March 2015 in Edinburgh. [8] He was reported to have been too ill to attend. [9]

Criticism

The final report of the Penrose Inquiry was widely branded a whitewash after it made only one recommendation, that steps should be taken to offer blood tests to anyone in Scotland who had a blood transfusion before 1991 and who has not already been tested for hepatitis C. The Inquiry did not apportion blame. [10] [11] [12] [13] [14] Andrea Summers, Solicitor to the Inquiry, attended a press conference to deliver the report and members of audience shouted 'whitewash' and 'cover up' as the audience walked out. [15]

Professor John Cash who was a former director of the Scottish National Blood Transfusion Service said the executives responsible were able to avoid giving evidence. "Did Lord Penrose get to speak to the people with the real answers? No, he didn't," "He tried but through no fault of his own he couldn't get to the truth. He ran into serious problems because the Inquiries Act meant there was a whole area he could not address". [14]

Five deaths were examined as outlined in the inquiry's terms of reference, these were, Reverend David Black, Mrs Eileen O'Hara, Alexander Black Laing, Neil Mullen and Victor Tamburrini. [2] Out of these 5 cases, only 1 of the victims was a Haemophiliac. The 1 haemophilia case was a Hepatitis C infection that occurred in the 1960s, before Factor concentrates were in use, meaning that the case did not relate to the relevant period which is regarded at the mid-1970s–1980s. [16] None of these examined cases involved HIV infection. [17]

Aftermath

Following the publication of the Penrose Inquiry, David Cameron became the first British Prime Minister to offer a formal apology for the scandal. [18] [19] [20]

No damages were paid during or following the inquiry, indeed, compensation was not mentioned within the terms of reference of the Penrose Inquiry. [21] Damages have, however, been paid in Ireland. [22] [23] [24] On 17 August 2022, the Government announced that victims of the infected blood scandal across England, Wales, Scotland and Northern Ireland will each receive an interim compensation payment of £100,000. [25]

See also

Related Research Articles

George William Penrose, Lord Penrose, PC, is a Scottish judge and member of the Privy Council who sat in the Court of Session, the supreme civil court.

Health Management Associates is a defunct Arkansas-based company involved in a blood-management scandal during the 1980s.

In the 1980s, between one and two thousand haemophilia patients in Japan contracted HIV via contaminated blood products. Controversy centered on the continued use of non-heat-treated blood products after the development of heat treatments that prevented the spread of infection. Some high-ranking officials in the Ministry of Health and Welfare, executives of the manufacturing company and a leading doctor in the field of haemophilia study were charged for involuntary manslaughter.

<span class="mw-page-title-main">Royal Commission of Inquiry on the Blood System in Canada</span> Royal commission of inquiry into the tainted blood scandal in Canada

The tainted blood disaster, or the tainted blood scandal, was a Canadian public health crisis in the 1980s in which thousands of people were exposed to HIV and hepatitis C through contaminated blood products. It became apparent that inadequately-screened blood, often coming from high-risk populations, was entering the system through blood transfusions. It is now considered to be the largest single (preventable) public health disaster in the history of Canada.

<i>Factor 8: The Arkansas Prison Blood Scandal</i> 2005 American film

Factor 8: The Arkansas Prison Blood Scandal is a feature-length documentary by Arkansas filmmaker and investigative journalist Kelly Duda. Through interviews and presentation of documents and footage, Duda alleges that in the 1970s and 1980s, the Arkansas prison system profited from selling blood plasma from inmates infected with viral hepatitis and HIV. The documentary contends that thousands of victims who received transfusions of blood products derived from these plasma products, Factor VIII, died as a result.

<span class="mw-page-title-main">Kelly Duda</span> American film director

Kelly Duda is an American filmmaker and activist from Arkansas best known for the 2005 documentary, Factor 8: The Arkansas Prison Blood Scandal.

Contaminated hemophilia blood products were a serious public health problem in the late 1970s up to 1985.

The Lindsay Tribunal was set up in Ireland in 1999 to investigate the infection of haemophiliacs with HIV and Hepatitis C from contaminated blood products supplied by the Blood Transfusion Service Board.

<span class="mw-page-title-main">Christine Lee (academic)</span> English medical researcher

Christine Lee is an English medical researcher. She is Emerita Professor of Haemophilia at the University of London, and founding Editor of Haemophilia. She trained in medicine at Somerville College, Oxford, where she was awarded First Class Honours and was the first female scholar of the Oxford University Medical School. She was awarded a Doctorate of Science (Medicine) by the University of London in 1996.

<span class="mw-page-title-main">Contaminated blood scandal in the United Kingdom</span> The historical contamination of blood products in the UK with HIV and hepatitis C virus

In the 1970s and 1980s, a large number of people – most of whom had haemophilia – were infected with hepatitis C and HIV, the virus that leads to acquired immune deficiency syndrome (AIDS), as a result of receiving contaminated clotting factor products. In the United Kingdom, these were supplied by the National Health Service (NHS) and many of the products were imported from the US.

<span class="mw-page-title-main">Patrick McGuire (solicitor)</span> Scottish solicitor and solicitor advocate

Patrick McGuire is a Scottish solicitor and solicitor advocate. He is a partner with personal injury law firm Thompsons Solicitors Scotland.

Arthur Leslie Bloom FCRP, FRCPath (1930–1992) was a Welsh physician focused on the field of Haemophilia.

Charles Rocco Carmine Rizza FRCPEd was a British consultant physician who specialised in haematology.

<span class="mw-page-title-main">John Cash (physician)</span> Scottish physician

John David Cash was president of the Royal College of Physicians of Edinburgh. He also served as Medical Director at the Scottish National Blood Transfusion Service from 1979 to 1988.

<i>R (March) v Secretary of State for Health</i> UK judicial review quashing a decision on the grounds of material error of fact

R (March) v Secretary of State for Health was a 2010 judicial review which challenged the UK Department of Health's decision not to implement Recommendation 6(h) of the Archer Independent Inquiry. The case was important in developing the doctrine of error of fact in public law which previously had not readily been the subject of judicial intervention.

M.C. and Others v Italy is a case decided by the European Court of Human Rights (ECHR) on 3 September 2013 in which Article 1 of Protocol 1 (A1P1) was engaged due to the applicants not being afforded annual uprating which the court deemed damage to their property of a disproportionate character in the form of an exorbitant charge. The Strasbourg ruling sets an important precedent for higher monthly compensation payments to be paid to the 60,000 or so victims of contaminated blood transfusions in Italy. The effect of this ruling increased payments to the applicants by 40%.

The Advisory Committee on the Virological Safety of Blood, often abbreviated to ACVSB, was a committee formed in March 1989 in the United Kingdom to devise policy and advise ministers and the Department of Health on the safety of blood with respect to viral infections. The scope of the ACVSB concerned areas of significant policy for the whole of the United Kingdom and operated under the terms of reference: "To advise the Health Departments of the UK on measures to ensure the virological safety of blood, whilst maintaining adequate supplies of appropriate quality for both immediate use and for plasma processing." Of particular emphasis to the remit was the testing of blood donors using surrogate markers for Non-A Non-B hepatitis (NANBH) and later on, HCV-screening of blood donors.

<i>HIV Haemophilia Litigation</i> Legal action by haemophiliacs infected with HIV through blood products

The HIV Haemophilia Litigation [1990] 41 BMLR 171, [1990] 140 NLJR 1349 (CA), [1989] E N. 2111, also known as AMcG002, and HHL, was a legal claim by 962 plaintiffs, mainly haemophiliacs, who were infected with HIV as a result of having been treated with blood products in the late 1970s and early 1980s. The first central defendants were the then Department of Health, with other defendants being the Licensing Authority of the time, (MCA), the CSM, the CBLA, and the regional health authorities of England and Wales. In total, there were 220 defendants in the action.

<i>CN v Secretary of State for Health and Social Care</i> Judicial review permission appeal challenging non-inclusion of hepatitis B

CN v Secretary of State for Health and Social Care [2022] EWCA Civ 86 was an appeal against the refusal of permission to apply for judicial review to challenge the infected blood support scheme administered by the NHS Business Services Authority (NHSBSA) for non-inclusion of those infected with chronic Hepatitis B virus. The appeal was based on the grounds that the exclusion of those infected with HBV from the England Infected Blood Support Scheme (EIBSS) was unreasonable and discriminatory, contrary to article 14 when read in conjunction with article 8 and article 1 protocol 1 (A1P1) of the ECHR. The appellant also claimed that there was different treatment and that the failure to include those infected with HBV was unreasonable, and that the original application for review should not have been deemed out of time.

The Irish Haemophilia Society (IHS) is an organization that represents the interests of people with haemophilia, von Willebrand disease and other inherited bleeding disorders.

References

  1. Keating, Fiona (16 April 2016). "World Haemophilia Day 2016: Contaminated blood scandal one of the biggest NHS treatment disasters". International Business Times UK. Retrieved 9 January 2017.
  2. 1 2 "Terms of Reference". www.penroseinquiry.org.uk. Retrieved 9 January 2017.
  3. R (March) v Secretary of State for Health , 765BMLR116 , 2(EWHC (Admin)2010)("There has never been any judicial consideration of liability or fault and never any statutory public inquiry.").
  4. "The Penrose Inquiry" (PDF). UK Government. Retrieved 7 January 2017.
  5. "Penrose Inquiry". www.penroseinquiry.org.uk. Retrieved 9 January 2017.
  6. "Who we are". www.childabuseinquiry.scot. Retrieved 9 January 2017.
  7. "Borders victim: Penrose report is 'a total whitewash'". ITV. 25 March 2015. Retrieved 9 January 2017.
  8. "Blood scandal victims condemn Penrose inquiry". www.scotsman.com. Retrieved 9 January 2017.
  9. "Chair of Penrose public inquiry seriously ill". HeraldScotland. 20 March 2015. Retrieved 9 January 2017.
  10. "Penrose report: Blood scandal inquiry branded a 'whitewash'" . The Independent. 25 March 2015. Archived from the original on 25 May 2022. Retrieved 9 January 2017.
  11. "Penrose Inquiry: £12m contaminated blood probe branded a whitewash". HeraldScotland. 26 March 2015. Retrieved 9 January 2017.
  12. "Victims cry 'whitewash' over Penrose blood infection inquiry, Scotland - BBC News". BBC. Retrieved 9 January 2017.
  13. "Victims Angry At Blood Inquiry 'Whitewash'". Sky News. Retrieved 9 January 2017.
  14. 1 2 Wheeler, Caroline (6 September 2015). "Six-year inquiry 'failed to find full awful truth about scandal of tainted blood'". Express.co.uk. Retrieved 9 January 2017.
  15. "Contaminated blood: Penrose report published / Cameron apology". www.gettyimages.co.uk. Retrieved 9 January 2017.
  16. "A bloody mess". The Guardian. 17 December 2002. ISSN   0261-3077 . Retrieved 9 January 2017.
  17. Tainted Blood (26 March 2015), The Penrose Inquiry / Chairman's Statement - 25th March 2015 , retrieved 9 January 2017
  18. "Penrose inquiry: David Cameron apologises over infected blood". BBC News. 25 March 2015. Retrieved 9 January 2017.
  19. Williams, Tryst (25 March 2015). "Prime Minister David Cameron apologises over contaminated blood scandal". walesonline. Retrieved 9 January 2017.
  20. CampaignTB (31 March 2015), Prime Minister's Questions : Formal Apology - Wednesday 25th March 2015 , retrieved 9 January 2017
  21. Jane Ellison, The Parliamentary Under-Secretary of State for Health (26 March 2015). "Penrose Inquiry". Parliamentary Debates (Hansard) . Vol. 594. Commons. col. 1596–1597. It is worth noting that the terms of reference given by the Scottish Government to the Penrose inquiry do not make reference to compensation.
  22. "Irish Hepatitis C Compensation Tribunal". www.hepccomptrib.com. Retrieved 9 January 2017.
  23. "€2.9m for victim of blood product contamination". 9 December 2016. Retrieved 9 January 2017.
  24. Bannon, Ultan. "Hep C & HIV Compensation Tribunal - Malcomson Law Solicitors". www.mlaw.ie. Archived from the original on 8 January 2017. Retrieved 9 January 2017.
  25. "Infected Blood victims to receive £100,000 interim compensation payment". GOV.UK. Cabinet Office. 17 August 2022. Retrieved 8 September 2022.